Search research articles
Contact Us
Filters
Showing results (111-120 of 184) with videos related to
Page
of 19
Sort By:
Cells
|
June 2, 2021
Expression of Immuno-Oncologic Biomarkers Is Enriched in Colorectal Cancers and Other Solid Tumors Harboring the A59T Variant of <i>KRAS</i>
Emil Lou, Joanne Xiu, Yasmine Baca, et al.
Head & Neck
|
November 12, 2025
Genomic and Immune Correlates of EZH2 Expression and Activity in Olfactory Neuroblastoma
Elisabetta Xue, Tolulope Adeyelu, Harris Krause, et al.
Journal of Neuro-Oncology
|
April 27, 2012
Bevacizumab therapy for adults with recurrent/progressive meningioma: a retrospective series
Emil Lou, Ashley L Sumrall, Scott Turner, et al.
Cancer Medicine
|
May 2, 2013
Phase II trial of upfront bevacizumab and temozolomide for unresectable or multifocal glioblastoma
Emil Lou, Katherine B Peters, Ashley L Sumrall, et al.
Endocrine-Related Cancer
|
June 13, 2025
Targeting anti-apoptosis as a therapeutic strategy in neuroendocrine neoplasms
Vineeth Sukrithan, Uzair Ahmed, Harris Krause, et al.
Cancers
|
June 29, 2019
Intercellular Transfer of Oncogenic KRAS via Tunneling Nanotubes Introduces Intracellular Mutational Heterogeneity in Colon Cancer Cells
Snider Desir, Phillip Wong, Thomas Turbyville, et al.
The Oncologist
|
July 27, 2019
Analysis of Differentially Expressed MicroRNAs and Circulating Tumor Cells as Predictive Biomarkers of Platinum Chemoresistance in Primary Ovarian Carcinomas: A Prospective Study
Emil Lou, Rachel I Vogel, Spencer Hoostal, et al.
NPJ Precision Oncology
|
January 20, 2026
Evaluation of immuno-oncologic biomarkers and β-catenin expression in response of hepatocellular carcinomas to immunotherapy
Gaurav Sharma, Yasmine Baca, Sanjay Goel, et al.
Plos One
|
January 6, 2016
Serum Biomarkers Associated with Clinical Outcomes Fail to Predict Brain Metastases in Patients with Stage IV Non-Small Cell Lung Cancers
Bob T Li, Emil Lou, Meier Hsu, et al.
JCO Precision Oncology
|
June 20, 2025
Molecular Correlates of Long-Term Response to Bevacizumab in Glioblastoma
John L Villano, Catherine R Garcia, Rachael M Morgan, et al.
Page
of 19
Search research articles
Search
Showing results (111-120 of 184) with videos related to
Sort By:
Page
of 19
Cells
|
June 2, 2021
Expression of Immuno-Oncologic Biomarkers Is Enriched in Colorectal Cancers and Other Solid Tumors Harboring the A59T Variant of <i>KRAS</i>
Emil Lou, Joanne Xiu, Yasmine Baca, et al.
Head & Neck
|
November 12, 2025
Genomic and Immune Correlates of EZH2 Expression and Activity in Olfactory Neuroblastoma
Elisabetta Xue, Tolulope Adeyelu, Harris Krause, et al.
Journal of Neuro-Oncology
|
April 27, 2012
Bevacizumab therapy for adults with recurrent/progressive meningioma: a retrospective series
Emil Lou, Ashley L Sumrall, Scott Turner, et al.
Cancer Medicine
|
May 2, 2013
Phase II trial of upfront bevacizumab and temozolomide for unresectable or multifocal glioblastoma
Emil Lou, Katherine B Peters, Ashley L Sumrall, et al.
Endocrine-Related Cancer
|
June 13, 2025
Targeting anti-apoptosis as a therapeutic strategy in neuroendocrine neoplasms
Vineeth Sukrithan, Uzair Ahmed, Harris Krause, et al.
Cancers
|
June 29, 2019
Intercellular Transfer of Oncogenic KRAS via Tunneling Nanotubes Introduces Intracellular Mutational Heterogeneity in Colon Cancer Cells
Snider Desir, Phillip Wong, Thomas Turbyville, et al.
The Oncologist
|
July 27, 2019
Analysis of Differentially Expressed MicroRNAs and Circulating Tumor Cells as Predictive Biomarkers of Platinum Chemoresistance in Primary Ovarian Carcinomas: A Prospective Study
Emil Lou, Rachel I Vogel, Spencer Hoostal, et al.
NPJ Precision Oncology
|
January 20, 2026
Evaluation of immuno-oncologic biomarkers and β-catenin expression in response of hepatocellular carcinomas to immunotherapy
Gaurav Sharma, Yasmine Baca, Sanjay Goel, et al.
Plos One
|
January 6, 2016
Serum Biomarkers Associated with Clinical Outcomes Fail to Predict Brain Metastases in Patients with Stage IV Non-Small Cell Lung Cancers
Bob T Li, Emil Lou, Meier Hsu, et al.
JCO Precision Oncology
|
June 20, 2025
Molecular Correlates of Long-Term Response to Bevacizumab in Glioblastoma
John L Villano, Catherine R Garcia, Rachael M Morgan, et al.
Page
of 19